In a new article from @biospace, Parexel's Charlotte Moser M.D. explores why patient centricity shouldn't just be an industry buzzword. It's how we accelerate innovation and get life-changing therapies to market faster. brnw.ch/21x2aPx

@Parexel @biospace Well said. True patient centricity improves trial design, retention, and outcomes—making it a real driver of faster, more effective innovation.